2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Culmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer With Brain MetastasesHR-positive, HER2-negative Metastatic Breast Cancer With Brain MetastasesNot yet recruitingPhase 22026-08-04NCT07745257
Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in Systemic Light Chain Amyloidosis PatientsSystemic Light Chain AmyloidosisRecruitingPhase 1 / Phase 22026-05-08NCT07266116